MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'aromatase inhibitors'. Sat, 03 Sep 2011 02:36:36 +0100 http://www.medworm.com/index.php?rid=3903099&cid=t_104880_136_f&fid=36032&url=http%3A%2F%2Fwww.everydayhealth.com%2Fblog%2Flife-with-breast-cancer%2Fdoes-tanned-and-wrinkled-mean-healthy-and-cancer-free%2F Recently my husband commented on how tan my feet are. I have been in love with flip-flops (also known as thongs) all summer long, so my feet are constantly exposed to the sun. I have been pretty careful about sun exposure since my early twenties. My skin has benefited from my caution, but with all the new information about vitamin D and its effects on cancer prevention, I wonder if this has been a good practice or not. I have written a little about the importance of vitamin D supplementation before, especially for women needing calcium or for those on hormonal drugs like aromatase inhibitors. Vitamin D may protect against bone loss in women taking Arimidex, a type of aromatase inhibitor, and lessen the bone, muscle, and joint pain that are known side effects of this drug. Now the effect of... Life with Breast Cancer blogs http://www.medworm.com/rss/comments.php?id=3903099 Wed, 25 Aug 2010 20:29:13 +0100 3903099 http://www.medworm.com/index.php?rid=2212648&cid=t_104880_136_f&fid=37846&url=http%3A%2F%2Fhealthinfoispower.wordpress.com%2F2009%2F02%2F24%2Feuropean-researchers-find-estrogen-receptor-gene-amplification-occurs-rarely-in-ovarian-cancer%2F “… ESR1 [gene] amplification is an uncommon mechanism for estrogen receptor overexpression in ovarian cancer occurring in about 2.1% of the total number of ovarian cancers. In general, this frequency parallels the fraction of ovarian cancers reported to show complete response to antiestrogenic [anti-hormonal] therapies. Given the strong predictive power of ESR1 [gene] amplification for [...] (Source: Libby's H*O*P*E*) Libby's H*O*P*E* blogs http://www.medworm.com/rss/comments.php?id=2212648 Tue, 24 Feb 2009 23:03:08 +0100 2212648 http://www.medworm.com/index.php?rid=1727798&cid=t_104880_136_f&fid=37846&url=http%3A%2F%2Fhealthinfoispower.wordpress.com%2F2008%2F08%2F18%2Fworking-smarter-not-harder-anti-estrogen-therapy-to-battle-recurrent-ovarian-cancer%2F The Gynecologic Oncology department of the University of Texas, M.D. Anderson Cancer Center took a page out of the breast cancer treatment “playbook,” and conducted a single institution Phase II clinical trial using letrozole (Femara®) to treat recurrent, platinum and taxane resistant, high-grade cancer of the ovary and peritoneum. …The trial investigators concluded that 26% [...] (Source: Libby's H*O*P*E*) Libby's H*O*P*E* blogs http://www.medworm.com/rss/comments.php?id=1727798 Tue, 19 Aug 2008 03:28:31 +0100 1727798 http://www.medworm.com/index.php?rid=1005423&cid=t_104880_136_f&fid=36051&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F180330117%2F In older women with early stage lung cancer, UCLA’s Jonsson Comprehensive Cancer Center researchers have discovered a novel mechanism to predict their survival. Higher levels of aromatase (an enzyme that naturally makes estrogen from another hormone called androgen) have, for the first time, been linked to more aggressive disease and lower survival rates in women over 65 with Stage 1 or 2 lung cancer. Such findings do not only provide possible need tool in predicting survival but also new target for therapy using aromatase inhibitors. According to the study’s senior author, Lee Goodglick, an associate professor in the UCLA Department of Pathology and Laboratory Medicine and a Jonsson Cancer Center researcher: “All indications suggest that this is a very powerful prognosti... Cancer Commentary blogs http://www.medworm.com/rss/comments.php?id=1005423 Tue, 06 Nov 2007 01:56:30 +0100 1005423 http://www.medworm.com/index.php?rid=486636&cid=t_104880_87_f&fid=35047&url=http%3A%2F%2Fwww.ideasforwomen.com%2Fnews%2Fwomens-health%2Fbreast-cancer%2F2007%2F02%2F12%2F116%2F A team led by Angela Cox of Sheffield University Medical School in the UK recently published in Nature Genetics the discovery of a gene that appears to decrease the chance of getting breast cancer in women of European descent by around 13%. The utilized data collected from 14 studies involving around 33,000 women. The gene is called CASP8 and is a member of the cysteine-aspartic acid protease family of genes also known as caspases. Caspases are involved in apoptosis, which is the programmed death of certain cells. Many cancers involve mutations in genes that are involved with apoptosis resulting in cancerous cells remaining alive despite having mutations that should have resulted in their dying through apoptosis. Recently the FDA approved a test that can help predict whether or not women w... Ideas For Women News Blog blogs http://www.medworm.com/rss/comments.php?id=486636 Mon, 12 Feb 2007 19:34:58 +0100 486636